{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:12:44Z","timestamp":1783732364280,"version":"3.55.0"},"reference-count":18,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jmsacl.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T12:50:01Z","timestamp":1709729401000},"page":"50-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Development and validation of an LC-MSMS method to quantify creatinine from dried blood spots"],"prefix":"10.21627","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6288-1291","authenticated-orcid":false,"given":"Carlos","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogers A.","family":"Muldrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa R.","family":"Naranjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Cotten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina C.","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina N.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"issue":"3","key":"10.1016\/j.jmsacl.2024.03.001_b0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5414\/CNWKDEditorial","article-title":"Kidney health for everyone everywhere - from prevention to detection and equitable access to care","volume":"93","author":"Li","year":"2020","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.jmsacl.2024.03.001_b0010","unstructured":"Rokhman MR, Alkaff FF, van Dorst PWM, et al. Economic evaluations of screening programs for chronic kidney disease: a systematic review. Value Health J. Int. Soc. Pharmacoecon. Outcomes Res. Published online August 31, 2023:S1098-3015(23)03092-9. 10.1016\/j.jval.2023.08.003."},{"issue":"9","key":"10.1016\/j.jmsacl.2024.03.001_b0015","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2337\/dc21-0723","article-title":"Chronic kidney disease testing among at-risk adults in the U.S. remains low: real-world evidence from a National Laboratory Database","volume":"44","author":"Alfego","year":"2021","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.jmsacl.2024.03.001_b0020","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/jalm\/jfad022","article-title":"AACC\/NKF guidance document on improving equity in chronic kidney disease care","volume":"8","author":"Pierre","year":"2023","journal-title":"J. Appl. Lab. Med."},{"issue":"4","key":"10.1016\/j.jmsacl.2024.03.001_b0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2215\/CJN.07580717","article-title":"Black Americans\u2019 perspectives of barriers and facilitators of community screening for kidney disease","volume":"13","author":"Umeukeje","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"issue":"1","key":"10.1016\/j.jmsacl.2024.03.001_b0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12882-019-1324-z","article-title":"Improving proteinuria screening with mailed smartphone urinalysis testing in previously unscreened patients with hypertension: a randomized controlled trial","volume":"20","author":"Leddy","year":"2019","journal-title":"BMC Nephrol."},{"issue":"5","key":"10.1016\/j.jmsacl.2024.03.001_b0035","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ajog.2019.06.015","article-title":"Feasibility and acceptability of home use of a smartphone-based urine testing application among women in prenatal care","volume":"221","author":"Burke","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jmsacl.2024.03.001_b0040","doi-asserted-by":"crossref","unstructured":"Papastergiou J, Donnelly M, Li W, Sindelar RD, van den Bemt B. Community pharmacy-based eGFR screening for early detection of CKD in high risk patients. Can. J. Kidney Health Dis. 2020;7:2054358120922617. 10.1177\/2054358120922617.","DOI":"10.1177\/2054358120922617"},{"issue":"6","key":"10.1016\/j.jmsacl.2024.03.001_b0045","doi-asserted-by":"crossref","first-page":"964","DOI":"10.2215\/CJN.11961115","article-title":"The see kidney disease targeted screening program for CKD","volume":"11","author":"Galbraith","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"10.1016\/j.jmsacl.2024.03.001_b0050","doi-asserted-by":"crossref","unstructured":"Figueroa-Solis E, Gimeno Ruiz de Porras D, Delclos GL. Pilot study determining the feasibility of implementing the Disadvantaged Populations eGFR Epidemiology Study (DEGREE) protocol, point-of-care field measurements and a new module on risk factors for chronic kidney disease of unknown origin in Hispanic outdoor workers. BMC Nephrol. 2021;22(1):88. 10.1186\/s12882-021-02288-z.","DOI":"10.1186\/s12882-021-02288-z"},{"key":"10.1016\/j.jmsacl.2024.03.001_b0055","unstructured":"Stoffel M, Beal SG, Ibrahim KA, Rummel M, Greene DN. Optimizing the data in direct access testing: information technology to support an emerging care model. Crit. Rev. Clin. Lab. Sci. Published online October 6, 2023:1-13. 10.1080\/10408363.2023.2258973."},{"issue":"9","key":"10.1016\/j.jmsacl.2024.03.001_b0060","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/clinchem\/hvac106","article-title":"Direct-to-consumer testing for routine purposes","volume":"68","author":"Stoffel","year":"2022","journal-title":"Clin. Chem."},{"issue":"13","key":"10.1016\/j.jmsacl.2024.03.001_b0065","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2212MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jmsacl.2024.03.001_b0070","unstructured":"Clinical Laboratory Improvement Amendments (CLIA) | CDC. Published January 16, 2024. Accessed January 27, 2024. https:\/\/www.cdc.gov\/clia\/index.html."},{"key":"10.1016\/j.jmsacl.2024.03.001_b0075","unstructured":"McDaniel L. Total Allowable Error Table. Data Innovations. Accessed January 27, 2024. https:\/\/www.datainnovations.com\/allowable-total-error-table\/."},{"issue":"7","key":"10.1016\/j.jmsacl.2024.03.001_b0080","doi-asserted-by":"crossref","first-page":"e0133912","DOI":"10.1371\/journal.pone.0133912","article-title":"LC-MSMS method for serum creatinine: comparison with enzymatic method and Jaffe method","volume":"10","author":"Ou","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmsacl.2024.03.001_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117689","article-title":"Dried blood spot analysis for the quantification of vancomycin and creatinine using liquid chromatography \u2013 tandem mass spectrometry: method development and validation","volume":"553","author":"Bahmany","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jmsacl.2024.03.001_b0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jmsacl.2023.10.002","article-title":"Matrix-matched calibrators are necessary for robust and high-quality dried blood spots lead screening assays by inductively coupled plasma-mass spectrometry","volume":"30","author":"Franco","year":"2023","journal-title":"J. Mass Spectrom. Adv. Clin. Lab."}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X2400018X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X2400018X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:47Z","timestamp":1767770567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X2400018X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":18,"alternative-id":["S2667145X2400018X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2024.03.001","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an LC-MSMS method to quantify creatinine from dried blood spots","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}